Concepedia

Anna M. Mc Laughlin

AM

Statistics

Publications

3

Citations

44

H-Index

3

Active since

2021

Affiliations

Freie Universität Berlin(Current)

Klinikum Stuttgart

University of Würzburg

Praxis für Hämatologie und Onkologie

University of Münster

Anna M. Mc Laughlin is an author at Freie Universität Berlin specializing in pharmacokinetics, cancer research, and oncology.

ORCID

Top concepts

Publications per year

2021–2024

3

Publications

3

Developing a Nationwide Infrastructure for Therapeutic Drug Monitoring of Targeted Oral Anticancer Drugs: The ON-TARGET Study Protocol

Anna M. Mc Laughlin, Eduard Schmulenson, Olga Teplytska et al. · Cancers · 2021 · 17 citations · Full text

, , +17

TLD-1, a novel liposomal doxorubicin, in patients with advanced solid tumors: Dose escalation and expansion part of a multicenter open-label phase I trial (SAKK 65/16)

Ilaria Colombo, Kira‐Lee Koster, Lisa Holer et al. · European Journal of Cancer · 2024 · 16 citations · Full text

Development and validation of a bioanalytical method for the quantification of axitinib from plasma and capillary blood using volumetric absorptive microsampling (VAMS) and on-line solid phase extraction (SPE) LC-MS

Patrick Opitz, Sebastian Zimmermann, Anna M. Mc Laughlin et al. · Journal of Pharmaceutical and Biomedical Analysis · 2022 · 11 citations

1–3 of 3